Literature DB >> 31902423

The High Cost of Insulin in the United States: An Urgent Call to Action.

S Vincent Rajkumar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31902423     DOI: 10.1016/j.mayocp.2019.11.013

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  8 in total

Review 1.  Radiotheranostics in oncology: current challenges and emerging opportunities.

Authors:  Lisa Bodei; Ken Herrmann; Heiko Schöder; Andrew M Scott; Jason S Lewis
Journal:  Nat Rev Clin Oncol       Date:  2022-06-20       Impact factor: 65.011

2.  Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia.

Authors:  Yazed AlRuthia; Ohud H Bahari; Suliman Alghnam; Ali M Alrumaih; Hassan Asiri; Mohammed Alshammari; Mansour Alhowimel; Hana A Al-Abdulkarim
Journal:  Front Public Health       Date:  2022-06-13

3.  The high cost of prescription drugs: causes and solutions.

Authors:  S Vincent Rajkumar
Journal:  Blood Cancer J       Date:  2020-06-23       Impact factor: 11.037

4.  Medication Shortages During the COVID-19 Crisis: What We Must Do.

Authors:  Esther K Choo; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2020-04-03       Impact factor: 7.616

Review 5.  The Causes of Insulin Resistance in Type 1 Diabetes Mellitus: Is There a Place for Quaternary Prevention?

Authors:  Marta Wolosowicz; Bartlomiej Lukaszuk; Adrian Chabowski
Journal:  Int J Environ Res Public Health       Date:  2020-11-21       Impact factor: 3.390

6.  How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Authors:  Michael J Haller; Laura M Jacobsen; Amanda L Posgai; Desmond A Schatz
Journal:  Diabetes       Date:  2021-02-25       Impact factor: 9.461

7.  A dashboard for exploring clinical trials sponsorship and potential virtual monopolies.

Authors:  S Scott Graham; Zoltan P Majdik; Joshua B Barbour; Justin F Rousseau
Journal:  JAMIA Open       Date:  2021-10-29

8.  The insulin market reaches 100.

Authors:  David Beran; Edwin A M Gale; John S Yudkin
Journal:  Diabetologia       Date:  2022-03-11       Impact factor: 10.460

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.